New FDA Approach Will Drive Big Changes in Contract Manufacturing Business.

Detalles Bibliográficos
Publicado en:BioPharm International Vol. 16; no. 11; pp. 18 - 19
Autor principal: Miller, Jim
Formato: Journal Article
Publicado: MJH Life Sciences Nov2003
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=108040928&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 108040928
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1542166X
        5NE
      jtl: BioPharm International
      issn: 1542166X
      maglogo: N
    pubinfo:
      dt: Nov2003
      vid: 16
      iid: 11
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        108040928
        2011967314
        108040928
      ppf: 18
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: New FDA Approach Will Drive Big Changes in Contract Manufacturing Business.
      aug:
        au: Miller, Jim
        affil: Publisher of Bio/Pharmaceutical Outsourcing Report (B/POR), PO Box 8163 Springfield, VA
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N